successfully deliver CS therapy to patients. It was centred on EULAR recommendations. Nine items were identified based on three main themes -safe prescribing, optimal dosing and prevention of complications. A questionnaire was created based on this discussion and all participants of the meeting were surveyed. Results: There are 21 centres providing rheumatology services in the South West England. All were represented in 30 participants of the survey. Median age of the nursing establishment was 48 years (mean 47 year, range 27-60 years). Only 6/30 (20%) were nurse prescribers. 14 (47%) did not feel comfortable advising patients on adjusting their CS dose. Only four (13%) had any patient group directive in place at their trust to enable them to amend CS dose for non-medical prescribers. 11 (36%) considered CS to be disease modifying therapy in inflammatory arthritis. 17 (56%) employed CS therapy as part of early arthritis management protocol. 4/30 (13%) considered prednisolone equivalent dose of 10mg/day safe in long term and seven (23%) would be happy to utilise 120mg IM depomedrone monthly as necessary. 10 (33%) were unaware of therapeutic co-intervention for CS related osteoporosis risk and 21 (70%) were not employing any fracture risk stratification tools. Conclusion: This pioneering initiative highlights a wide variation in the prescription standards of a key job provision. Very few units have independent nurse prescribers. Others lack patient group directive to at least enable non-medical prescribers i.e. RNSs to safely amend CS therapy prescribed by a rheumatologist. Less than a quarter of those surveyed actually consider CSs to have any disease-modifying role. Rather worryingly, some do not even recognise the safe long-term CS dose and willing to offer high doses periodically. Though most know the concomitant therapeutic options to mitigate against osteoporosis, few are actually assessing fracture risk thereby unlikely to offer the appropriate interventions.
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In conclusion, there is wide variation in the service provision of RNSs. This can potentially have a negative impact on effort to promote safer use of CSs in the management of inflammatory rheumatic diseases. There is a need for improving training standards to help deliver good quality rheumatology professionals of the future and ensure safe and effective drug interventions. Disclosures: The authors have declared no conflicts of interest. Background: ANCA-associated vasculitis is a rare multisystem disease. Modern therapeutic protocols have turned ANCA-associated vasculitis from an acute frequently fatal disease into a chronic disease requiring long-term immunosuppression. Patients must often manage substantial burdens related to chronic illness and treatment-related side effects. Patients often need help and support to manage their disease. The aim of this study was to explore the experience of patients and of informal carers of patients about the impact of managing a rare rheumatic condition. Methods: A qualitative approach using semi-structured interviews was used. Interviews were conducted with a purposeful sample of 18 pairs of patients with ANCA-associated vasculitis and their informal carers. The interviews were used to explore the participants experience and affects of caring. The interviews were recorded and transcribed as verbatim text and analysed using the framework technique. Results: 18 patients (seven female) [disease: ten granulomatosis with polyangiitis (GPA); four microscopic polyangiitis (MPA); four eosinophilic granulomatosis with polyangiitis (EGPA), age range 34-78, disease duration 1-20 years. Caregiver and patient perspectives were shared. The emerging themes were the physical and psychological impact of the disease, the need for constant vigilance and fear of the future. Conclusion: Both patients and carers faced a range of challenges in managing a rare condition. From the seriousness of the illness, dealing with the emotional toll and knowing what to expect. This study offers insight into the experiences of patients and informal carers and health care professionals should address individuals' fears and expectations for recovery. Disclosures: J.M. honoraria; Abbvie, Bristol Myres Squibb. K.G. and R.A.W. have declared no conflicts of interest. Background: Reducing Arthritis Fatigue by clinical Teams using cognitive-behavioural approaches (RAFT) is a seven-centre RCT of a manualised group cognitive-behavioural (CB) programme to reduce fatigue impact. After four days training plus a delivery observed by clinical supervisors, tutor pairs (rheumatology nurses and occupational therapists (OTs)) delivered the programme four times to patients with RA. Quality assurance observations confirmed tutors used CB approaches and RAFT results show the programme reduced patients' fatigue impact at 26 weeks. The aim of the current study was to understand tutors' experiences of RAFT training and delivery to inform future programme roll out. Methods: 14 RAFT tutors (nine nurses; five OTs) participated in oneto-one interviews, which were audio-recorded and transcribed. Data were analysed by ED, SH, and AH using inductive thematic analysis. Results: Four main themes were identified. Theme 1: It's quite daunting -Delivering a complex programme that was ''quite different to what any of us had done before'' required time and effort (''I couldn't really make sense of it without actually doing a lot of work around it''). Initially, training with clinical supervisors (experts) who are ''so good at what they do'' challenged tutors' confidence (''the anxiety is are we going to deliver it the way they did?''). Theme 2: Most useful was actually getting to practice the sessions -Tutors valued watching clinical supervisors demonstrate programme sessions during training (''professionals who have shown us how to do it'') plus the opportunity to practice themselves (''role playing the sessions was really helpful''). Theme 3: Putting it in a way that was still true to the message -the RAFT manual was ''very valuable'' and ''it had to be adhered to''; however, tutors wrote individual crib notes (''our own manual in our own words'') to consolidate information, deepen understanding, and gain confidence. The process was supported by ''positive and constructive criticism'' in the observed delivery (''the supervisor kept putting us back on track''). Theme 4: As a practitioner I feel enriched -CB skills acquired during RAFT impacted tutors' wider work (''making a massive difference to my clinical practice''), and enhanced the selfmanagement support they offered patients, including ''the particular ability to draw things out from people'' and ''learning when to listen and stand back and try and get the patients to find the answers''. Conclusion: Initially, RAFT training and delivery were a challenge for tutors because the CB approach was a new way of working. Individually adapting RAFT manual wording plus feedback from supervisors increased tutors' confidence. Tutors believed the CB skills acquired during RAFT enhanced their wider clinical practice and the self-management support they offered patients. Future training should include RAFT session demonstrations and skills practice for tutors, with feedback from clinical supervisors. Disclosures: The authors have declared no conflicts of interest. 
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